About BioLight
BioLight is a publicly listed company based in Tel Aviv (Israel) founded in 2005. Diagnostics and therapeutics for ophthalmology. The company has 4 employees. Its chief executive, as recorded, is Suzana Nahum Zilberberg. Its focus areas include Life Sciences, Ophthalmology and In-Vitro Diagnostic Tests.
Company details
BioLight is focused on the discovery, development and commercialization of products that address ophthalmic conditions such as glaucoma, dry eye syndrome, or DES, and age-related macular degeneration, or AMD. The company current portfolio is held through its wholly owned subsidiary XLVision, and includes Eye-D (an in-office insertable platform that provides for controlled release of ophthalmic medications over time), IOPtiMate (a surgical system that enables a non-penetrating, CO2 laser-assisted procedure known as CLASS (CO2 Laser-Assisted Sclerotomy Surgery) to reduce elevated IOP), TeaRx ( a diagnostic solution that provides a multi-parameter, objective, rapid, simple, semi-quantitative analysis of tear film in order to identify one or more underlying causes of DES), and OphRx (a non-invasive topical drug delivery technology). BioLight also owns 46 of Micromedic Inc.
- Headquarters Tel Aviv, Israel
- Employees 4
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bio-light.co.il
- Social LinkedIn YouTube
- Legal Name Biolight Life Sciences Ltd.
- Net Profit-$3.68 M (USD)-64.2as on Dec 31, 2025
- EBITDA-$4.6 M (USD)-53.99as on Dec 31, 2025
- Employee Count4
Apps and channels of BioLight
its YouTube channel BioLight Life Sciences has 0026 subscribers.
People of BioLight
6 people are tracked at BioLight (4 in leadership, 2 in team); the tracked headcount is 4.
| Name | Role | Group |
|---|---|---|
Suzana Nahum Zilberberg | CEO | Leadership |
Eran Eilat | Founder And Director | Leadership |
Shimon Gross | Chief Executive Officer | Leadership |
Amos Sommer | Chief Technology Officer | Leadership |
Vincente Anido Jr. | Dr. Vincente Anido Jr. | Team |
Hila Barash | Researcher | Team |
Complete people profiles for BioLight
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of BioLight
BioLight is a publicly listed company on the TASE with ticker symbol BOLT in Israel, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date25 Feb 2010
- Listed onTLV: BOLT
- Listed entityBioLight Life Sciences Ltd.
- Exchange sectorHealth technology
- ISINIL0010952237
- Share price270.70 ILA (+0.45% on the day) · 2026-10-12
- Market capitalisation24,577,582.00 ILA
- Volume (last session)1,749
Financials of BioLight
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | -11.7M ILS | -14.7M ILS | |
| 2024 | 219,000 ILS | -7.1M ILS | -9.5M ILS |
| 2023 | 118,000 ILS | -26.0M ILS | -10.1M ILS |
| 2022 | 63,000 ILS | -7.8M ILS | -9.7M ILS |
| 2021 | 3,000 ILS | 382,000 ILS | -10.1M ILS |
Detailed financial statements for BioLight
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of BioLight
Websites that share an audience with BioLight (bio-light.co.il).
Websites whose visitors overlap most with BioLight. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
nashim.net | nashim.net | 100% | #4,577,786 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biolight
Complete news archive for BioLight
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioLight
BioLight was founded in 2005.
BioLight is headquartered in Tel Aviv, Israel.
Suzana Nahum Zilberberg is the CEO of BioLight, as recorded in our data.
BioLight has 4 employees.
BioLight is focused on the discovery, development and commercialization of products that address ophthalmic conditions such as glaucoma, dry eye syndrome, or DES, and age-related macular degeneration, or AMD. The company current portfolio is held through its wholly owned subsidiary XLVision, and includes Eye-D (an in-office insertable platform that provides for controlled release of ophthalmic medications over time), IOPtiMate (a surgical system that enables a non-penetrating, CO2 laser-assisted procedure known as CLASS (CO2 Laser-Assisted Sclerotomy Surgery) to reduce elevated IOP), TeaRx ( a diagnostic solution that provides a multi-parameter, objective, rapid, simple, semi-quantitative analysis of tear film in order to identify one or more underlying causes of DES), and OphRx (a non-invasive topical drug delivery technology). BioLight also owns 46 of Micromedic Inc.
Yes, BioLight is publicly traded on TASE under the ticker symbol BOLT.